About Cocoon Biotech
Cocoon Biotech is a company based in Boston (United States) founded in 2013. Cocoon Biotech has raised $2.88 million across 7 funding rounds from investors including MassChallenge and The Venture Forum. The company has 3 employees. Cocoon Biotech offers products and services including EcoSilk™ and Silk-Based Solutions. Cocoon Biotech operates in a competitive market with competitors including Spintex, among others.
- Headquarter Boston, United States
- Employees 3
- SectorsChemicals & Materials
- Email••••••••
- Website cocoonbiotech.com
- Social LinkedIn X Facebook
- Legal Name Cocoon Biotech, Inc
- Total Equity Funding$2.88M (USD)
in 7 rounds
- Latest Funding Round$865.41K (USD), Series A
Oct 2020
- InvestorsMassChallenge
& 1 more
- Employee Count3
Products & Services of Cocoon Biotech
Cocoon Biotech offers a comprehensive portfolio of products and services, including EcoSilk™ and Silk-Based Solutions.
Natural protein from silkworm cocoons replacing petrochemicals in products.
Versatile material for healthcare and industrial applications as eco-alternatives.
Funding Insights of Cocoon Biotech
Cocoon Biotech has successfully raised a total of $2.88M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $865.41 thousand completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.88M
- Total Rounds 7
- Last Round Series A — $865,408
- First Round $10,000
(Jun 2013)
- Investors Count 2
All 7 funding rounds of Cocoon Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $865,408 | Series A | – | – | – |
| Nov 2019 | $4.5M | Debt – Conventional | – | – | – |
| Oct 2015 | $1.81M | Series A | – | – | – |
| Jun 2014 | $200,000 | Seed | – | – | – |
| May 2014 | – | Grant | – | – | |
| Nov 2013 | $22,000 | Grant | – | – | – |
| Jun 2013 | $10,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Cocoon Biotech
Cocoon Biotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include MassChallenge and The Venture Forum.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage entrepreneurs are accelerated through MassChallenge's program. | – | masschallenge.org | Boston, United States | |
A startup community in Central Massachusetts supporting entrepreneurs. | – | theventureforum.org | Worcester, United States |
Investor details for Cocoon Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cocoon Biotech
5 people are tracked at Cocoon Biotech (2 in leadership, 3 in board & advisors); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Mike Santos | VP, R&D | Leadership |
Ailis Tweed-Kent | CEO & Founder | Leadership |
Mary Thistle | Board Member | Board & advisors |
Charles Koppel | Board Member | Board & advisors |
Annalisa Jenkins | Board Member | Board & advisors |
Complete people profiles for Cocoon Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cocoon Biotech
3 dated milestones of Cocoon Biotech across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Cocoon Biotech is founded.
- Funding First funding round of $10K.
- Funding Latest funding round, Series A, of $865K.
Competitors of Cocoon Biotech
Cocoon Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Spintex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| spintex.co.uk | 2018 | Oxford, United Kingdom | $463,853 | 2 | Developer of sustainable textiles using silk materials |
Detailed competitors of Cocoon Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cocoon Biotech
Complete news archive for Cocoon Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cocoon Biotech
10 companies that operate in the same segment as Cocoon Biotech (Battery & Advanced Material Systems), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
AI and app-based smart windows are provided for buildings. | 2007 | Milpitas, California, United States | USD 3.71 B | – | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Mycelium-based leather alternative fabrics are manufactured and provided. | 2009 | Emeryville, California, United States | USD 219.4 M | USD 1.37 M | 22 | |
Bio-based materials from mycelium are manufactured as sustainable leather alternatives. | 2013 | Emeryville, California, United States | USD 225.3 M | – | – | |
Manufacturer of carbon fiber composites for multiple industrial applications | 2018 | Berkeley, California, United States | USD 233.13 M | – | – | |
Developr of bio-based products and natural compounds for biotechnological solutions | 1993 | Zwingenberg, Hesse, Germany | USD 5.38 M | – | – | |
Sustainable biodegradable materials are developed using mycelium technology. | 2007 | Albany, United States | USD 183.93 M | – | 106 | |
Technology is developed to convert carbon dioxide into raw materials. | 2011 | Macclesfield, Cheshire, United Kingdom | USD 43.19 M | – | – | |
Meta-optic materials are manufactured for applications in sensing and electronics. | 2016 | Weston, Florida, United States | USD 47.4 M | – | 26 | |
Biodegradable packaging materials are manufactured from crop stubble waste. | 2020 | Delhi, Delhi, India | USD 3.45 M | USD 45.41 K | 55 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cocoon Biotech
Cocoon Biotech was founded in 2013.
Cocoon Biotech is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Cocoon Biotech is a funded company, having raised a total of $2.88M across 7 funding rounds to date. The company's 1st funding round was a Grant of $10K, raised on Jun 2013.
Cocoon Biotech has 3 employees.
Provider of a biocompatible silk protein for the treatment of osteoarthritis and other degenerative joint disorders. the companys platform technology is a biocompatible silk protein that can be injected into joints to provide long-lasting pain relief and potentially delay the progression of the disease.
Cocoon Biotech's top competitors include Spintex.
Cocoon Biotech offers EcoSilk™ and Silk-Based Solutions.
Cocoon Biotech has 2 investors. Key investors include MassChallenge, and The Venture Forum.
Cocoon Biotech operates through Cocoon Biotech, Inc.